These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 7993881)

  • 1. Regulation of phospholipid degradation and biosynthesis in the heart by isoprenaline: effect of mepacrine.
    Nováková O; Drnková J; Kubista V; Novák F
    Physiol Res; 1994; 43(3):151-6. PubMed ID: 7993881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the phospholipid content in the left heart ventricle of male mice during repeated administration of isoprenaline.
    Drnková J; Nováková O; Kubista V
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 95(2):125-31. PubMed ID: 1977548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Ca2+ in phosphatidylinositol response and arachidonic acid release in formylated tripeptide- or Ca2+ ionophore A23187-stimulated guinea pig neutrophils.
    Takenawa T; Homma Y; Nagai Y
    J Immunol; 1983 Jun; 130(6):2849-55. PubMed ID: 6406597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phospholipase inhibitors and calcium antagonists on the changes in myocardial phospholipids induced by isoproterenol.
    Takasu N; Hashimoto H; Miyazaki Y; Ito T; Ogawa K; Satake T
    Basic Res Cardiol; 1988; 83(5):567-75. PubMed ID: 3233096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of membrane phospholipids in myocardial injury induced by ischemia and reperfusion.
    Das DK; Engelman RM; Rousou JA; Breyer RH; Otani H; Lemeshow S
    Am J Physiol; 1986 Jul; 251(1 Pt 2):H71-9. PubMed ID: 2942042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dantrolene and mepacrine antagonize the hemolysis of human red blood cells by halothane and bee venom phospholipase A2.
    Fletcher JE; Kistler P; Rosenberg H; Michaux K
    Toxicol Appl Pharmacol; 1987 Sep; 90(3):410-9. PubMed ID: 3660410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phospholipase A2 inhibitors. Differential inhibition of fatty acid acylation into kidney lipids by mepacrine and p-bromophenacyl bromide.
    Erman A; Azuri R; Raz A
    Biochem Pharmacol; 1983 Jul; 32(13):2083-7. PubMed ID: 6870935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mepacrine protects the isolated rat heart during hypoxia and reoxygenation--but not by inhibition of phospholipase A2.
    Bugge E; Gamst TM; Hegstad AC; Andreasen T; Ytrehus K
    Basic Res Cardiol; 1997 Feb; 92(1):17-24. PubMed ID: 9062648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of phospholipids in isolated guinea pig hearts stimulated with isoprenaline.
    Jakab G; Rapundalo ST; Solaro RJ; Kranias EG
    Biochem J; 1988 Apr; 251(1):189-94. PubMed ID: 3390153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of angiotensin II on arachidonate metabolism in adrenal glomerulosa cells.
    Hunyady L; Balla T; Enyedi P; Spät A
    Biochem Pharmacol; 1985 Oct; 34(19):3439-44. PubMed ID: 3931645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ca2+-antagonistic properties of phospholipase A2 inhibitors, mepacrine and chloroquine.
    Filippov A; Skatova G; Porotikov V; Kobrinsky E; Saxon M
    Gen Physiol Biophys; 1989 Apr; 8(2):113-8. PubMed ID: 2777057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on mitochondrial and microsomal phospholipids and phospholipase A2 in heart from rats subjected to prolonged exercise.
    Keatisuwan W
    Hokkaido Igaku Zasshi; 1992 Jul; 67(4):488-97. PubMed ID: 1427593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of alteration by propranolol and mepacrine of the metabolism of phosphoinositides and other glycerolipids in the rabbit iris muscle.
    Abdel-Latif AA; Smith JP; Akhtar RA
    Biochem Pharmacol; 1983 Dec; 32(24):3815-21. PubMed ID: 6318773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase of phosphatidylinositol arachidonic acid incorporation induced by mepacrine.
    Sterin-Speziale NB; Setton CP; Kahane VL; Speziale EH
    Biochem Pharmacol; 1989 Mar; 38(5):725-8. PubMed ID: 2495005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of arachidonic acid metabolism in resident and BCG-activated alveolar macrophages: role of lyso(bis)phosphatidic acid.
    Cochran FR; Roddick VL; Connor JR; Thornburg JT; Waite M
    J Immunol; 1987 Mar; 138(6):1877-83. PubMed ID: 3102603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mepacrine, a phospholipase inhibitor. A potential tool for modifying myocardial reperfusion injury.
    Otani H; Engelman RM; Breyer RH; Rousou JA; Lemeshow S; Das DK
    J Thorac Cardiovasc Surg; 1986 Aug; 92(2):247-54. PubMed ID: 3736082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between inhibition of arachidonic acid release and prevention of calcium loading during ATP depletion in cultured rat cardiac myocytes.
    Jones RL; Miller JC; Hagler HK; Chien KR; Willerson JT; Buja LM
    Am J Pathol; 1989 Sep; 135(3):541-56. PubMed ID: 2506756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity of three phospholipid analogues towards inhibition of phospholipase A2 in macrophages.
    Letourneux Y; Bourass J; Boucrot P; Elkihel L; Petit JY
    Pharmacol Res; 1997 Jan; 35(1):73-8. PubMed ID: 9149319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The resistance of liposomes as potential drug carriers to the action of phospholipase A2].
    Litvinko NM; Shumilina TA; Naubatova MK; Akhrem AA
    Prikl Biokhim Mikrobiol; 1993; 29(3):478-84. PubMed ID: 8516280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of polymorphonuclear leucocyte phospholipase A2 activity by chloroquine and mepacrine.
    Authi KS; Traynor JR
    J Pharm Pharmacol; 1982 Nov; 34(11):736-8. PubMed ID: 6129307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.